---
title: "Shanghai Pharmaceuticals Gets Registration Certificate for Sitagliptin/Metformin Tablets"
description: "Shanghai Pharmaceuticals Gets Registration Certificate for Sitagliptin/Metformin Tablets"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/274912761.md"
published_at: "2026-02-05T04:20:13.000Z"
---

# Shanghai Pharmaceuticals Gets Registration Certificate for Sitagliptin/Metformin Tablets

### Related Stocks

- [510660.CN - ChinaAMC SSE Health Care ETF Initiating Fund](https://longbridge.com/en/quote/510660.CN.md)
- [02607.HK - SH PHARMA](https://longbridge.com/en/quote/02607.HK.md)
- [589720.CN - Guotai SSE STAR Brand Name Drug ETF](https://longbridge.com/en/quote/589720.CN.md)
- [601607.CN - Shanghai Pharma](https://longbridge.com/en/quote/601607.CN.md)
- [600216.CN - ZMC](https://longbridge.com/en/quote/600216.CN.md)
- [588860.CN - ICBCCS SSE STAR Biology and Medicine ETF](https://longbridge.com/en/quote/588860.CN.md)
- [159316.CN - E Fund Hang Seng SCHK Innovative Drug ETF](https://longbridge.com/en/quote/159316.CN.md)
- [159929.CN - China Universal 800 Health Care ETF](https://longbridge.com/en/quote/159929.CN.md)
- [560600.CN - Founder Fubon CSI Medicine and Medical Device Innovation ETF](https://longbridge.com/en/quote/560600.CN.md)
- [512010.CN - E Fund CSI 300 Health Care ETF](https://longbridge.com/en/quote/512010.CN.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | Sino Biopharmaceutical says NMPA approved Benmelstobart injection for marketing | [Link](https://longbridge.com/en/news/276024005.md) |
| Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug | Sino Biopharmaceutical has received Chinese regulatory approval for its PD-L1 inhibitor, benmelstobart, for use as maint | [Link](https://longbridge.com/en/news/276016059.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/en/news/276035104.md) |
| Elon Musk’s Neuralink sparks BCI race in China | Neuralink, founded by Elon Musk, is driving a surge in brain-computer interface (BCI) development in China, with startup | [Link](https://longbridge.com/en/news/276460367.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.